Shape CopyShapeLEARN MORE Group 4Rectangle 5 CopyFacebookRectangle 7 Copy 3Consulting IconPage 1Products IconTraining IconGroup 4Group 3Shape Copy 3Shape CopyIRETA-Logo-02Left ArrowRight ArrowLocationMenuSearchFacebookGoogle PlusLinkedInTwitterYoutube
Addiction Research, Education and Training | IRETA
MenuClose
Menu
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
  • Overview
  • Blog
  • Contact
  • Home
  • MyIRETA
Addiction Research, Education and Training | IRETA
  • Home
  • Who We Are
  • Blog
  • Contact
  • myIRETA
  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Useful & Credible Sources
  • Case Studies
  • All Resources
Resources

Substance Use Disorder Care: Pandemic and Beyond

Posted on January 6, 2021 by Marla Kauffman

**Please note, we do not provide CEUs for viewing recorded webinars. If you are interested in receiving CEUs, you canĀ view and register for our upcoming webinars here.**

The presentation will review the impact of the current global pandemic on substance use, overdose, and health care utilization. The pandemic has forced health care providers to rapidly adjust the method of care delivery and patient engagement. In particular, telehealth utilization has surged across all specialties including addiction care. We will discuss telehealth legislation and regulation, including temporary waivers that have permitted broader access to care, the evidence to support telehealth for opioid use disorder treatment, specifically, and future considerations once the public health emergency has finally ended.

During this webinar you will learn how to:
-Discuss impact of the pandemic on individuals with substance use disorders
-Present data regarding overdose, hospital visits, and naloxone utilization during the pandemic
-Review data on telehealth treatment of substance use disorders
-Discuss federal and state telehealth legislation, temporary waivers, and role in future expansion of health care access

Presenter
Michael Lynch, MD
Medical Director, Pittsburgh Poison Center
Medical Director, UPMC Health Plan Substance Use Disorder Services
Assistant Professor
Division of Medical Toxicology, Department of Emergency Medicine
Divisions of Adolescent and Pediatric Emergency Medicine, Department of Pediatrics
University of Pittsburgh School of Medicine

  • Type

  • Topics

  • Consulting
    • Overview
    • Our Process
    • For the Criminal Justice System
    • For Addiction Treatment Providers
    • For Healthcare Service Organizations
  • Training
    • Overview
    • Upcoming Webinars
    • Online Courses
    • Training Resources
  • Evaluation
    • Overview
    • Program Evaluation
    • Clinical Guideline Development
  • About Addiction
    • Overview
    • Addiction and Recovery Basics
    • Glossary
    • Useful & Credible Sources

611 William Penn Place, Suite 403 Pittsburgh, PA 15219 | P: 412-258-8565 | F: 412-391-2528
Terms & Conditions | Privacy Policy
© 2021 IRETA | Website by Imagebox.

Subscribe